Signaling Pathways
-
A1615 GANT611 CitationTarget: GLISummary: GLI antagonist
-
A1655 GW25801 CitationTarget: CSF-1RSummary: CFMS kinase/CSF-1R inhibitor,selective and ATP-competitive
-
A1174 AMG-517Target: TRP ChannelSummary: TRPV1 antagonist,potent and highly selective
-
A1387 AZD53633 CitationTarget: AktSummary: AKT inhibitor,pyrrolopyrimidine derived
-
A2689 ButeinTarget: Src|STAT|EGFR|Angiotensin-Converting Enzymes (ACEs)|5-Lipoxygenases|PTK|enoyl-acyl-carrier protein reductaseSummary: Protein kinase inhibitor
-
A2173 SC 1441 CitationTarget: GlycoproteinsSummary: Gp130 inhibitor
-
A1769 KU-00606481 CitationTarget: PI3K|DNA-PKSummary: Dual DNA-PK/PI3-K inhibitor, ATP-competitive
-
A2664 VX-661Target: CFTRSummary: F508del CFTR corrector
-
A1794 LY2835219Target: Cyclin-Dependent KinasesSummary: CDK4/6 inhibitor,potent and selective
-
A1720 Duvelisib (IPI-145, INK1197)Target: PI3KSummary: PI3K-δ/PI3K-γ inhibitor